tiprankstipranks
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market
Want to see GLUE full AI Analyst Report?

Compare Monte Rosa Therapeutics (GLUE) vs. Competitors

382 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Monte Rosa Therapeutics
$19.78
$1.53B
-6.06
368.99%
7 Buy
0 Hold
0 Sell
Strong Buy
CytomX Therapeutics
$4.82
$785.91M
-11.41
80.50%
9 Buy
0 Hold
0 Sell
Strong Buy
Fulcrum Therapeutics
$8.29
$445.78M
-7.74
1.36%
7 Buy
1 Hold
1 Sell
Moderate Buy
Monopar Therapeutics Inc
$56.22
$397.05M
-30.03
49.86%
7 Buy
0 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$85.32
$1.59B
-7.83
803.83%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GLUE
Monte Rosa Therapeutics
18.15
14.04
341.61%
CTMX
CytomX Therapeutics
3.61
1.48
69.48%
FULC
Fulcrum Therapeutics
6.69
-0.24
-3.46%
MNPR
Monopar Therapeutics Inc
59.27
22.37
60.62%
OPT
INBX
Inhibrx Biosciences Inc
108.64
96.17
771.21%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts